Latest InterMune Inc. Stories
FLINT, Mich., Oct.
BASEL, Switzerland, Sept. 29, 2014 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and InterMune, Inc.
BRISBANE, Calif., Sept. 19, 2014 /PRNewswire/ -- InterMune, Inc.
BRISBANE, Calif., Sept. 5, 2014 /PRNewswire/ -- InterMune, Inc.
-- Transformational H1 2014 includes presentation of Phase 3 ASCEND data, NDA resubmission and target PDUFA date of Nov. 23 for pirfenidone in U.S. - BRISBANE, Calif., Aug.
BRISBANE, Calif., July 28, 2014 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that it will release its second quarter 2014 financial results at the close of the U.S.
CHICAGO, July 21, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog.
BRISBANE, Calif., July 17, 2014 /PRNewswire/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that pirfenidone has been granted Breakthrough Therapy Designation from the U.S.
Editor Note: For more information about this release, please scroll to bottom. LONDON, July 7, 2014 /PRNewswire/ -- On Thursday, July 03, 2014, the NASDAQ Composite
- Large; stout; burly.